Research update
Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy

https://doi.org/10.1016/S0165-6147(02)02103-XGet rights and content

Abstract

α-Melanocyte stimulating hormone (α-MSH) and other melanocortin peptides are potent anti-inflammatory agents that exhibit efficacy in many animal models of acute and chronic inflammation. These peptides are produced both centrally and peripherally, and exert their biological actions via activation of membrane-bound receptors. To exploit the therapeutic potential of such anti-inflammatory peptides, it is essential that the receptor subtype mediating these effects is identified with certainty.

Section snippets

Melanocortins and inflammation

α-MSH has long been reported to be active in models of allergic and chronic inflammation, potently suppressing oedema formation and inhibiting leukocyte migration. Some α-MSH actions might be due to the C-terminal tripeptide KPV that corresponds to α-MSH11–13 (Fig. 1b). For example, the KPV tri-peptide antagonizes the binding of interleukin 1β (IL-1β) to its receptor, suggesting that α-MSH might also function as an IL-1 receptor antagonist [3]. This action might explain the anti-pyretic effect

Which melanocortin receptor modulates inflammation?

Two receptor candidates (MC3 and MC1) with different tissue distributions and levels of cellular expression have been proposed to be responsible for modulating the anti-inflammatory effects of melanocortin.

The MC1 receptor has long been regarded as the receptor responsible for the anti-inflammatory effects of α-MSH and related peptides [1]. Using flow cytometry, Anderson et al. found expression of MC1 receptor in monocytes, B cells, natural killer cells and a subset of cytoxic T cells, but not

Pharmacological effects of melanocortin peptides in other pathological models

Until recently, most studies have focused on the anti-inflammatory effects of melanocortin peptides in experimental models of acute and, to a lesser extent, chronic inflammation. Melanocortins have multiple biological actions; for example, they exert a protective effect in a rat model of myocardial infarct [17] and in models of endotoxin-induced colonic inflammation [18] and mesenteric ischaemia–reperfusion injury [19]. Other disease models have been shown to be susceptible to melanocortin

Concluding remarks

The role played by melanocortin peptides in modulating the host inflammatory response is beyond doubt. Along with many other anti-inflammatory substances these peptides play a protective role in maintaining the homeostatic balance within the body. The receptor type involved in modulating the inflammatory response has yet to be identified with certainty, although the availability of mice with non-functional MC1 receptors or the generation of knockout MC3 receptors [20] will help to address this

Chemical names

HS024Ac-Cys-Nle-Arg-His-dNal(2′)-Arg-Trp-Gly-Cys-NH2
MTIIAc-Nle-c[Asp-His-dPhe-Arg-Trp-Lys]-NH2
SHU9119Ac-Nle-c[Asp-His-dNal(2′)-Arg-Trp-Lys]-NH2

Acknowledgements

I would like to thank the Arthritis Research Campaign, UK (grant no. PO562) for their continued support.

References (20)

There are more references available in the full text version of this article.

Cited by (65)

  • Memory impairment induced by IL-1β is reversed by α-MSH through central melanocortin-4 receptors

    2009, Brain, Behavior, and Immunity
    Citation Excerpt :

    This clear neuroprotective effect occurring at low doses is probably mediated by brain melanocortin MC4 receptors. Melanocortins are widely distributed in the CNS and MC4 receptors have been found in various brain areas including the hippocampus (Getting, 2002). Administration of HS014, a selective MC4R antagonist, reversed the effect of α-MSH on the impairment of memory consolidation induced by IL-1β suggesting that α-MSH may exert this effect by activating central MC4R.

  • Glial Cells Response in Stroke

    2023, Cellular and Molecular Neurobiology
View all citing articles on Scopus
View full text